We look forward to seeing you at Sleep 2018!
Avadel is currently enrolling patients with narcolepsy and cataplexy for our REST-ON Phase III trial evaluating once-nightly sodium oxybate. Visit Booth #360 to find out more about the REST-ON trial, patient eligibility, and our patient referral program.
Avadel Pharmaceuticals plc is committed to providing solutions for overlooked and unmet medical needs through patient-focused, innovative products. www.avadel.com